Tetracycline

matrix metallopeptidase 2 ; Homo sapiens







13 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 28257106 Tetracycline Reduces Kidney Damage Induced by Loxosceles Spider Venom. 2017 Mar 2 1
2 24125013 Structural and dynamics analysis of matrix metalloproteinases MMP-2 complexed with chemically modified tetracyclines (CMTs). 2014 Dec 1
3 18673015 Host-response therapeutics for periodontal diseases. 2008 Aug 1
4 17237909 A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas. 2007 Aug 2
5 17261708 Microglial activation and matrix protease generation during focal cerebral ischemia. 2007 Feb 1
6 16242193 Chemically modified tetracyclines (CMT-3 and CMT-8) enable control of the pathologic remodellation of human aortic valve stenosis via MMP-9 and VEGF inhibition. 2006 Aug 28 4
7 16018756 Tetracycline at subcytotoxic levels inhibits matrix metalloproteinase-2 and -9 but does not remove the smear layer. 2005 Jul 3
8 12479698 Targeting the tumor microenvironment with chemically modified tetracyclines: inhibition of laminin 5 gamma2 chain promigratory fragments and vasculogenic mimicry. 2002 Nov 1
9 11469893 Metalloproteinase inhibition prevents acute respiratory distress syndrome. 2001 Aug 1
10 10776921 Analysis of in situ protease activity in chronic adult periodontitis patients: expression of activated MMP-2 and a 40 kDa serine protease. 2000 Mar 1
11 10438572 Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes. 1999 Aug 25 1
12 9972128 Tetracycline-based MMP inhibitors can prevent fibroblast-mediated collagen gel contraction in vitro. 1998 Nov 1
13 7978787 Doxycycline and chemically modified tetracyclines inhibit gelatinase A (MMP-2) gene expression in human skin keratinocytes. 1994 Sep 6 2